ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 5 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Results 1 - 20 of 128 : 1 2 3 4 5 6 7 Next »

Recs

0
Member Avatar StockMarketKid13 (71.60) Submitted: 6/21/2015 8:22:34 PM : Outperform Start Price: $64.05 ISIS Score: -10.95

good

Recs

0
Member Avatar Treborn822 (79.57) Submitted: 4/16/2015 1:33:31 AM : Outperform Start Price: $65.02 ISIS Score: -11.55

Alot of drugs in the pipeline

Recs

0
Member Avatar marsuculix (62.67) Submitted: 3/25/2015 4:04:07 AM : Outperform Start Price: $68.43 ISIS Score: -15.97

for me, ISIS is definitely a buy at $ <70 !

Recs

1
Member Avatar oncqueen (71.60) Submitted: 2/20/2015 9:49:42 AM : Outperform Start Price: $66.25 ISIS Score: -13.49

They have a new anticoagulant which in 300 humans, given preoperatively for knee replacement, yielded NO clots (as opposed to 15% for Lovenox) and a bleeding risk of 5%, compared to 8% for Lovenox. This is a game-changer.

Recs

0
Member Avatar BACnumber1 (< 20) Submitted: 2/14/2015 1:55:25 PM : Outperform Start Price: $63.74 ISIS Score: -10.22

Almost as good as GWPH

Recs

4
Member Avatar scoopemall (32.72) Submitted: 12/18/2014 10:21:48 PM : Outperform Start Price: $63.05 ISIS Score: -10.65

Total game changer for healthcare community

Recs

1
Member Avatar Tophinater (23.20) Submitted: 12/5/2014 10:30:01 AM : Outperform Start Price: $53.99 ISIS Score: +3.71

Jihad!

Recs

0
Member Avatar Evermore (< 20) Submitted: 11/4/2014 11:20:59 AM : Outperform Start Price: $45.37 ISIS Score: +18.79

RNAi platform with immense potential

Recs

1
Member Avatar usubanas (99.75) Submitted: 9/4/2014 3:45:09 AM : Outperform Start Price: $40.25 ISIS Score: +33.56

Long term super holding. Their impressive pipeline more than justifies their ~$4B enterprise value.

Recs

3
Member Avatar MotleyViking (94.88) Submitted: 6/18/2014 7:03:55 PM : Outperform Start Price: $35.55 ISIS Score: +48.52

Deep pipeline, seemingly has a lot of promise/potential with several drugs.Could be a takeover target, though I don't think there is a much of a chance for that. Value for ISIS is all about their pipeline so we'll see what happens going forward.

Recs

1
Member Avatar Turdtwistr (66.00) Submitted: 6/17/2014 10:21:59 AM : Outperform Start Price: $34.62 ISIS Score: +51.57

great pipeline

Recs

1
Member Avatar Gclever88 (37.37) Submitted: 6/13/2014 5:11:55 PM : Outperform Start Price: $33.60 ISIS Score: +56.22

Like the future possibilities of drug in pipeline.

Recs

1
Member Avatar km00nster (< 20) Submitted: 6/13/2014 3:39:23 PM : Outperform Start Price: $30.61 ISIS Score: +69.72

One of the best pipelines in the industry. Should easily surpass 40 by years end.

Recs

2
Member Avatar RedandBlack (96.73) Submitted: 6/5/2014 10:51:57 PM : Outperform Start Price: $30.58 ISIS Score: +71.56

$3B market cap with $600M+ in cash and ST investments and not burning cash due to partnerships with big pharma. Good pipeline appears to make this a solid outperform.

Recs

1
Member Avatar monkeykat (21.06) Submitted: 5/23/2014 6:34:33 PM : Outperform Start Price: $29.05 ISIS Score: +78.56

Great pipeline of drugs and excellent work being done with their RNA treatments.

Recs

1
Member Avatar infinitesimal (68.21) Submitted: 5/14/2014 4:24:52 PM : Outperform Start Price: $25.33 ISIS Score: +103.62

the one or the other will come through finally

Recs

1
Member Avatar FTownBryan (< 20) Submitted: 4/12/2014 12:53:56 PM : Outperform Start Price: $49.81 ISIS Score: -2.29

good value on the pullback. time to load up.

Recs

0
Member Avatar NHWeston102 (20.43) Submitted: 3/12/2014 11:30:25 AM : Outperform Start Price: $50.41 ISIS Score: +0.46

Poised to enter the biotech majors, ISIS has pipeline, partnerships, and profits.

Recs

0
Member Avatar rule72 (37.85) Submitted: 2/6/2014 11:13:48 AM : Outperform Start Price: $29.87 ISIS Score: +70.50

This stock seen it grow from $8 to now $46.7 there was a report from barron around May of 2013 saying this stock was not worth keeping or buying. Well that was when around $30 now it is at $ 46
came out with a new drug. So even ones that think they know everything can be wrong.

Recs

1
Member Avatar Wildabeast04 (< 20) Submitted: 1/6/2014 2:53:41 PM : Outperform Start Price: $38.79 ISIS Score: +28.93

Huge pipeline of drugs with great space for growth.

Featured Broker Partners